Vol. 29.Issue. 1. January - February 2024 | Annals of Hepatology

Tienda Elsevier

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

4.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

9.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

1.011

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

1.057

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

portada-S1665268123X00076

Vol. 29. Issue 1.

(January - February 2024)

Editorial

Ending stigmatizing language in alcohol and liver disease: A liver societies' statement

Ann Hepatol. 2024;29:101143

Full text access

Share

Opinions

Why a pinch of zinc in liver disease matters

Kurt Grüngreiff, Dirk Reinhold, Wolfgang Maret

Ann Hepatol. 2024;29:101152

Full text access

Share

Concise reviews

Alcohol-associated liver disease: Epidemiology and management

Helena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller

Ann Hepatol. 2024;29:101162

Full text access

Share

Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?

Caecilia HC Sukowati, Korri El-Khobar, Chyntia Olivia Maurine Jasirwan, Juferdy Kurniawan, Rino Alvani Gani

Ann Hepatol. 2024;29:101153

Full text access

Share

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group

Ann Hepatol. 2024;29:101133

Full text access

Share

Original articles

Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma

Xingyuan Hao, Jinghua Li, Bin Liu, Wei Jing, Yonghua Guo, Fusheng Liu, Xiaomian Li, Xi Chen, ... Weijie Ma

Ann Hepatol. 2024;29:101160

Full text access

Share

A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomes

Lauren Loeb, Jason Lewis, Zhongwei Peng, Michael G. Heckman, Raouf Nakhleh, Andrew P. Keaveny

Ann Hepatol. 2024;29:101164

Full text access

Share

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues

Yan Gu, Yao Zhang, Zhiyi Zhang, Jian Wang, Qing Zhang, Shaoqiu Zhang, Yilin Liu, Jiacheng Liu, ... Chao Wu

Ann Hepatol. 2024;29:101151

Full text access

Share

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study

Renling Yao, Sufang Lu, Ruifei Xue, Jian Wang, Yuanwang Qiu, Yuxin Chen, Jiacheng Liu, Li Zhu, ... Chao Wu

Ann Hepatol. 2024;29:101155

Full text access

Share

Trajectories of patients relisted for liver transplantation

Fakhar Ali Qazi Arisar, Rhea Varghese, Shiyi Chen, Wei Xu, Markus Selzner, Ian McGilvray, Blayne Sayed, Trevor Reichman, ... Mamatha Bhat

Ann Hepatol. 2024;29:101168

Full text access

Share

Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis

Jiaying Wu, Jiayao He, Hongmei Xu

Ann Hepatol. 2024;29:101158

Full text access

Share

Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia

Marina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić

Ann Hepatol. 2024;29:101156

Full text access

Share

Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018

Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang

Ann Hepatol. 2024;29:101154

Full text access

Share

Prevalence of post-liver transplant complications and NASH-related cirrhosis in postmenopausal women

Natalia Salinas Parra, Michelle Schafer, Heather M. Ross, John Bruckbauer, Brian Yan, Sarah L. Chen, Adnan Khan, Danielle M. Tholey, Dina Halegoua-DeMarzio

Ann Hepatol. 2024;29:101157

Full text access

Share

Letters to the editor

Schistosomiasis: A neglected cause of liver disease in the Philippines

Alexander M. Sy

Ann Hepatol. 2024;29:101166

Full text access

Share

Balancing perspectives: Schistosomiasis in the liver disease landscape of the Philippines

Eric David Ornos, Janus P. Ong

Ann Hepatol. 2024;29:101165

Full text access

Share

Surgical resection versus transcatheter arterial chemoembolization for large hepatocellular carcinoma: a deeper insight

Aimen Waqar Khan, Sarah Waqar Khan

Ann Hepatol. 2024;29:101163

Full text access

Share

Special issue on hot topics in hepatology a multinational perspective

Evolving portal hypertension through Baveno VII recommendations

Manuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos

Ann Hepatol. 2024;29:101180

Full text access

Share